Best of ASCO - 2014 Annual Meeting

 

Welcome

Local-Regional Therapy

Breast Cancer—Local/Regional/Adjuvant

2018 ASCO Annual Meeting

Sort by: title abstract no. first author
ABSTRACT TITLEFIRST AUTHORABSTRACT NO.
Association of clinical/pathological parameters with axillary involvement in early breast cancer in patients with limited sentinel node involvement (< 3 LK) after neoadjuvant chemotherapy (NACT).

Hans-Christian Kolberg

559

At surgery for a core needle biopsy diagnosis of ductal carcinoma in situ with microinvasion: Is sentinel lymph node biopsy required?

Meghan Rose Flanagan

563

Baseline quality of life evaluation in older women with primary operable breast cancer and its relationship with different treatments.

Ross A. Zahit

e12601

CA15-3/MUC1 in CCTG MA-32 (NCT01101438): A phase III RCT of the effect of metformin vs. placebo on invasive disease free and overall survival in early stage breast cancer (BC).

Ryan JO Dowling

557

Clinical and phylogenetic factors affecting the detection of genomic variants in circulating cell-free DNA for patient with primary breast cancer.

Yidong Zhou

e12600

Comparative effectiveness of sentinel lymph node biopsy for patients with ductal carcinoma in situ.

Shi-Yi Wang

e12602

Comparison of breast conservative therapy to mastectomy in male breast cancer: A NCDB analysis.

Sarah Bateni

565

Comparison of operative to monitoring and endocrine therapy for low-risk DCIS (COMET study).

Thomas Lynch

TPS599

Contralateral prophylactic mastectomy, social economics, and informed medical decision making.

Hadeel Assad

e12622

Correlation of pathologic and radiologic complete response in the axilla after neoadjuvant chemotherapy for breast cancer.

Jessica Charlotte Gooch

e12611

Early stage in triple negative breast cancer: Breast conservative surgery versus mastectomy.

Gabriel Antonio De la Cruz Ku

e12619

Effectiveness of biomarker surveillance after treatment in locoregional breast cancer.

Timothy J Brown

e12608

Fabrication and application of supine MRI-based 3D brest surgical guide for precise breast conserving surgery in breast cancer patients.

Beomseok Ko

e12612

Factors associated with lymphedema in patients/women with node positive breast cancer treated with neoadjuvant chemotherapy and axillary dissection on a prospective clinical trial.

Judy Caroline Boughey

513

Fifteen-year results of the randomised EORTC trial 22922/10925 investigating internal mammary and medial supraclavicular (IM-MS) lymph node irradiation in stage I-III breast cancer.

Philip Poortmans

504

Fluorescent endoscopic breast surgery to detect the sentinel node and the tumor for aesthetics of breast conserving therapy.

Koji Yamashita

e12610

Frequency of locoregional recurrence among locally advanced HER2-positive breast cancer treated with modern multimodality therapy.

Lior Zvi Braunstein

e12604

Hypofractionated whole breast IMRT and brachytherapy boost after conservative surgery for breast cancer: Early results of a prospective non-randomised trial.

Ines Guix

560

Intraoperative lumpectomy cavity margin analysis with far-red fluorescence to reduce volume of tissue excised during breast cancer lumpectomy surgery.

Conor Lanahan

e12605

Isosulfan blue: Rates of perioperative anaphylaxis—A single center retrospective analysis.

Vinay Goswamy

e12617

Lymphovascular invasion and extranodal tumor extension as risk indicators of breast cancer-related lymphedema.

Nicola Fusco

e12609

Palliative radiotherapy (RT) to the breast using a novel hypofractionated radiotherapy regime: Results of the HYPORT phase I/II study (CTRI/2015/12/006407).

Sanjoy Chatterjee

e12613

Percentages of post-mastectomy patients presenting with perinodal extension or inadequate axillary dissection in STAGE I and II carcinoma breast.

Maitrik Mehta

e12618

PET avidity and tumor clinical and pathological features in breast cancer.

Ahmed Gamal Elsayed

e12623

POSNOC: Positive Sentinel Node—Adjuvant therapy alone versus adjuvant therapy plus clearance or axillary radiotherapy.

Amit Goyal

TPS600

Post neoadjuvant chemotherapy vacuum assisted biopsy in breast cancer: Can it determine pathologic complete response before surgery?

Marios Konstantinos Tasoulis

567

Prediction of pathologic complete response by image-guided biopsy before surgery in breast cancer with complete clinical response to neoadjuvant chemotherapy: A prospective feasibility trial.

Han-Byoel Lee

566

Prognostic impact of multifocal and multicentric breast cancer compared with unifocal breast cancer.

Atsushi Fushimi

e12614

Prospective phase II multicenter trial of ablation after breast lumpectomy added to treat (ABLATE) breast cancer without radiation.

V. Suzanne Klimberg

562

Results from a pilot of an innovative 4R Cancer Care Delivery Model in early breast cancer: Impact on timing and sequencing of guideline recommended care.

Christine B. Weldon

561

Sentinel lymph node biopsy using super magnetic iron oxide and an original magnetic probe in Japan.

Kanae Taruno

e12603

Single center long term results from the randomized phase-3 TARGIT-A trial comparing intraoperative (IORT) and whole-breast radiation therapy (WBRT) for early breast cancer.

Yasser Abo-Madyan

e12616

The experience of the usage of intraoperative radiation therapy after neoadjuvant systemic therapy for breast cancer.

Aleksei Manikhas

e12621

Time to surgery and the impact of delay on triple negative breast cancers and other phenotypes.

Alina M. Mateo

e12606

Ultrasound-guided restaging and localization of axillary lymph nodes after neoadjuvant chemotherapy for guidance of axillary surgery in breast cancer patients: Experience with activated charcoal.

Soo Jung Lee

e12615